• 沒有找到結果。

鈣離子釋出是細胞凋亡的指標之一 65, 66 。在癌細胞中,鈣離子主要儲 存於內質網 67 ,內質網最主要的功能為幫助蛋白質摺疊成穩定的結構和分

泌蛋白質。當內質網受到破壞後,會有大量折疊錯誤的蛋白質聚集或鈣 離子通透失衡,會產生所謂的內質網壓力 (ER stress)25。當 ER stress 時,

GRP78 (glucose-regulated protein 78) 和 GADD153 (growth arrest and DNA damage inducible gene 153) 這兩種基因會大量表現68。有文獻提及,

GADD153 能抑制 Bcl-2 及促進 Bax 的表現以調控細胞凋亡66,因此鈣 (Intrinsic pathway) 以及內質網壓力 (Endoplasmic reticulum stress, ER stress )17。內在路徑細分為凋亡蛋白酶依賴 (caspase dependent) 路徑以即 凋亡蛋白非依賴 (caspase independent) 路徑。凋亡蛋白酶依賴路徑主要 受到 Bcl-2 家族的調控,因其結合至粒線體膜上影響膜電位,使粒線體 功能喪失進而釋放 cytochrome c,並與 caspase-9 結合,活化 caspase-3 而走向細胞凋亡;凋亡蛋白非依賴路徑主要是因 Bcl-2 蛋白家族結合至 粒線體膜上形成孔洞,導致粒線體間質釋出 apoptosis-inducing factor

(AIF) 和 endonuclease G (Endo G) 至細胞質中,進而轉位進入細胞核 內,造成 DNA 受損及斷裂,最後走向細胞凋亡69。這些蛋白的釋放被認 為與粒線體膜上稱為 mitochondrial permeability transition pore (MPTP) 的巨大通道有關,有研究顯示, MPTP 的開啟被認為是使粒線體膜電位 下降的主要因素之一。在本研究中,NCI-H460 細胞經魚藤素加藥處理 後,可活化促凋亡相關蛋白 (Bid, Bax, Bak) 和抑制抗凋亡蛋白 (Bcl-2, Bcl-X) 的表現 (圖十八),至使粒腺體膜電位下降 (圖十七) ,釋出 AIF 和 cytochrome c (圖十八),cytochrome c, Apaf-1 和 caspase-9 結合形成凋 亡體,活化caspase-3 (圖十八),且利用 CaspaLux kit 偵測 caspase-3 的 活性,亦也證實 caspase-3 之活性明顯上升 (圖二十);另一方面, AIF 轉 位至細胞核中造成 DNA 受損引發細胞凋亡 (圖十九)。以上結果證實魚 藤素能經由粒線體內在路徑誘導 NCI-H460 細胞凋亡。

第五章 結論

魚藤素能有效抑制人類非小細胞肺癌 NCI-H460 細胞株的增生,造成 細胞死亡而降低細胞存活率;並且誘發細胞凋亡和 DNA 受損,致使磷 脂絲胺酸蛋白外翻 , DNA 斷裂和染色質濃縮形成凋亡小體。

經由西方墨點法和免疫螢光染色法證實,魚藤素會抑制 p-AKT 蛋白 表現,促進 BAD 的活化,並且使之從細胞質轉位至粒腺體外膜上,與 Bcl-2 或 Bcl-X 結合,進而影響促細胞凋亡相關蛋白 (Bid, Bax, Bak) 和 抑制抗凋亡蛋白 (Bcl-2, Bcl-X) 的表現,至使粒腺體膜電位下降,釋出 AIF 和 cytochrome c。cytochrome c, Apaf-1 和 caspase-9 結合形成凋亡 體,活化caspase-3,最後誘發細胞凋亡;然而,AIF 轉移至細胞核中造 成 DNA 受損。

總觀以上結果,我們認為魚藤素會引起人類非小細胞肺癌 NCI-H460 細胞株之粒腺體功能喪失並誘導細胞經由 Akt 和 Bad 相關粒腺體內在 路徑走向細胞凋亡。

圖二十七 魚藤素誘導人類非小細胞肺癌 (NCI-H460) 細胞凋亡路徑圖

第六章 參考文獻

1. 行政院衛生署.【cite;Available from http://www.doh.gov.tw/.(2009) 】 2. 世界衛生組織.【cite;Available from http://www.who.int./en/.(2009) 】 3. DeMarini DM, Claxton LD. Outdoor air pollution and DNA damage. Occup Environ Med 2006;63(4): 227-9.

4. Furuta M, Hayakawa K, Saito Y, et al. Clinical implication of symptoms in patients with non-small cell lung cancer treated with definitive radiation therapy. Lung Cancer 1995;13(3): 275-83.

5. Murray N, Turrisi AT, 3rd. A review of first-line treatment for small-cell lung cancer. J Thorac Oncol 2006;1(3): 270-8.

6. Clegg A, Scott DA, Hewitson P, Sidhu M, Waugh N. Clinical and cost effectiveness of paclitaxel, docetaxel, gemcitabine, and vinorelbine in non-small cell lung cancer: a systematic review. Thorax 2002;57(1): 20-8.

7. Portugal J, Bataller M, Mansilla S. Cell death pathways in response to antitumor therapy.

Tumori 2009;95(4): 409-21.

8. 醫學百科. 【cite;http://big5.wiki8.com/yuteng_81614/】

9. 台灣野生植物資料庫. 【cite;http://plant.tesri.gov.tw/plant/.】

10. 台南縣本土教育資源網. 【cite;http://ltrc.tnc.edu.tw/modules/tadbook2】. 11. Kuehne FC, Bethe U, Freedberg K, Goldie SJ. Treatment for hepatitis C virus in human immunodeficiency virus-infected patients: clinical benefits and cost-effectiveness.

Arch Intern Med 2002;162(22): 2545-56.

12. Murillo G, Salti GI, Kosmeder JW, 2nd, Pezzuto JM, Mehta RG. Deguelin inhibits the growth of colon cancer cells through the induction of apoptosis and cell cycle arrest. Eur J Cancer 2002;38(18): 2446-54.

13. Li R, Chen Y, Shu WX, Chen Z, Ke WJ. Involvement of SRC-3 in deguelin-induced apoptosis in Jurkat cells. Int J Hematol 2009;89(5): 628-35.

14. Chen Y, Wu Q, Cui GH, Chen YQ, Li R. Deguelin blocks cells survival signal pathways and induces apoptosis of HL-60 cells in vitro. Int J Hematol 2009;89(5): 618-23.

15. Chun KH, Kosmeder JW, 2nd, Sun S, et al. Effects of deguelin on the phosphatidylinositol 3-kinase/Akt pathway and apoptosis in premalignant human bronchial epithelial cells. J Natl Cancer Inst 2003;95(4): 291-302.

16. Kindt TJ OB, Goldsby RA. Kuby Immunology 2006.

17. Budihardjo I, Oliver H, Lutter M, Luo X, Wang X. Biochemical pathways of caspase activation during apoptosis. Annu Rev Cell Dev Biol 1999;15: 269-90.

18. Raffray M, Cohen GM. Apoptosis and necrosis in toxicology: a continuum or distinct modes of cell death? Pharmacol Ther 1997;75(3): 153-77.

19. Ferri KF, Kroemer G. Organelle-specific initiation of cell death pathways. Nat Cell Biol 2001;3(11): E255-63.

20. Jacobson MD, Burne JF, King MP, Miyashita T, Reed JC, Raff MC. Bcl-2 blocks apoptosis in cells lacking mitochondrial DNA. Nature 1993;361(6410): 365-9.

21. Susin SA, Lorenzo HK, Zamzami N, et al. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 1999;397(6718): 441-6.

22. Wajant H. The Fas signaling pathway: more than a paradigm. Science 2002;296(5573):

1635-6.

23. Bredesen DE, Rao RV, Mehlen P. Cell death in the nervous system. Nature 2006;443(7113): 796-802.

24. Rutkowski DT, Kaufman RJ. A trip to the ER: coping with stress. Trends Cell Biol 2004;14(1): 20-8.

25. Joo JH, Liao G, Collins JB, Grissom SF, Jetten AM. Farnesol-induced apoptosis in human lung carcinoma cells is coupled to the endoplasmic reticulum stress response.

Cancer Res 2007;67(16): 7929-36.

26. Coffer PJ, Woodgett JR. Molecular cloning and characterisation of a novel putative protein-serine kinase related to the cAMP-dependent and protein kinase C families. Eur J Biochem 1991;201(2): 475-81.

27. Altomare DA, Guo K, Cheng JQ, Sonoda G, Walsh K, Testa JR. Cloning, chromosomal localization and expression analysis of the mouse Akt2 oncogene. Oncogene 1995;11(6): 1055-60.

28. Franke TF, Yang SI, Chan TO, et al. The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase. Cell 1995;81(5): 727-36.

29. Andjelkovic M, Suidan HS, Meier R, Frech M, Alessi DR, Hemmings BA. Nerve growth factor promotes activation of the alpha, beta and gamma isoforms of protein kinase B in PC12 pheochromocytoma cells. Eur J Biochem 1998;251(1-2): 195-200.

30. Franke TF, Kaplan DR, Cantley LC, Toker A. Direct regulation of the Akt proto-oncogene product by phosphatidylinositol-3,4-bisphosphate. Science 1997;275(5300): 665-8.

31. James SR, Downes CP, Gigg R, Grove SJ, Holmes AB, Alessi DR. Specific binding of the Akt-1 protein kinase to phosphatidylinositol 3,4,5-trisphosphate without subsequent activation. Biochem J 1996;315 ( Pt 3): 709-13.

32. Staal SP, Hartley JW, Rowe WP. Isolation of transforming murine leukemia viruses from mice with a high incidence of spontaneous lymphoma. Proc Natl Acad Sci U S A 1977;74(7): 3065-7.

33. Staal SP, Hartley JW. Thymic lymphoma induction by the AKT8 murine retrovirus. J Exp Med 1988;167(3): 1259-64.

34. Datta SR, Brunet A, Greenberg ME. Cellular survival: a play in three Akts. Genes Dev 1999;13(22): 2905-27.

35. Vivanco I, Sawyers CL. The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat Rev Cancer 2002;2(7): 489-501.

36. Hajduch E, Litherland GJ, Hundal HS. Protein kinase B (PKB/Akt)--a key regulator of glucose transport? FEBS Lett 2001;492(3): 199-203.

37. Brazil DP, Hemmings BA. Ten years of protein kinase B signalling: a hard Akt to follow. Trends Biochem Sci 2001;26(11): 657-64.

38. Scheid MP, Woodgett JR. PKB/AKT: functional insights from genetic models. Nat Rev Mol Cell Biol 2001;2(10): 760-8.

39. Teixeira C, Reed JC, Pratt MA. Estrogen promotes chemotherapeutic drug resistance by a mechanism involving Bcl-2 proto-oncogene expression in human breast cancer cells.

Cancer Res 1995;55(17): 3902-7.

40. Kane LP, Shapiro VS, Stokoe D, Weiss A. Induction of NF-kappaB by the Akt/PKB kinase. Curr Biol 1999;9(11): 601-4.

41. Nicholson KM, Anderson NG. The protein kinase B/Akt signalling pathway in human malignancy. Cell Signal 2002;14(5): 381-95.

42. Shou Y, Li L, Prabhakaran K, Borowitz JL, Isom GE. Calcineurin-mediated Bad translocation regulates cyanide-induced neuronal apoptosis. Biochem J 2004;379(Pt 3):

805-13.

43. She QB, Solit DB, Ye Q, O'Reilly KE, Lobo J, Rosen N. The BAD protein integrates survival signaling by EGFR/MAPK and PI3K/Akt kinase pathways in PTEN-deficient

tumor cells. Cancer Cell 2005;8(4): 287-97.

44. PET scanning said to save money and improve staging of lung cancer. Oncology (Williston Park) 1995;9(11): 1200.

45. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65(1-2): 55-63.

46. Ito S, Oyake T, Murai K, Ishida Y. Deguelin suppresses cell proliferation via the inhibition of survivin expression and STAT3 phosphorylation in HTLV-1-transformed T cells. Leuk Res 2010;34(3): 352-7.

47. Ji BC, Hsu WH, Yang JS, et al. Gallic acid induces apoptosis via caspase-3 and mitochondrion-dependent pathways in vitro and suppresses lung xenograft tumor growth in vivo. J Agric Food Chem 2009;57(16): 7596-604.

48. Wagner L, Lai E. Separation of large DNA molecules with high voltage pulsed field gel electrophoresis. Electrophoresis 1994;15(8-9): 1078-83.

49. Liao W, McNutt MA, Zhu WG. The comet assay: a sensitive method for detecting DNA damage in individual cells. Methods 2009;48(1): 46-53.

50. Vermes I, Haanen C, Reutelingsperger C. Flow cytometry of apoptotic cell death. J Immunol Methods 2000;243(1-2): 167-90.

51. Tan TW, Tsai HR, Lu HF, et al. Curcumin-induced cell cycle arrest and apoptosis in human acute promyelocytic leukemia HL-60 cells via MMP changes and caspase-3 activation. Anticancer Res 2006;26(6B): 4361-71.

52. Lu HF, Hsueh SC, Yu FS, et al. The role of Ca2+ in (-)-menthol-induced human promyelocytic leukemia HL-60 cell death. In Vivo 2006;20(1): 69-75.

53. Wada A, Fukui K, Sawai Y, et al. Pamidronate induced anti-proliferative, apoptotic, and anti-migratory effects in hepatocellular carcinoma. J Hepatol 2006;44(1): 142-50.

54. Donaldson JG. Immunofluorescence staining. Curr Protoc Immunol 2002;Chapter 21:

Unit 21 3.

55. Hovelmann S, Beckers TL, Schmidt M. Molecular alterations in apoptotic pathways after PKB/Akt-mediated chemoresistance in NCI H460 cells. Br J Cancer 2004;90(12):

2370-7.

56. Lee H, Lee JH, Jung KH, Hong SS. Deguelin promotes apoptosis and inhibits angiogenesis of gastric cancer. Oncol Rep 2010;24(4): 957-63.

57. Chu ZH, Liang XH, Zhou XL, Huang RF, Zhan QZ, Jiang JW. [Effects of deguelin on proliferation and apoptosis of MCF-7 breast cancer cells by phosphatidylinositol 3-kinase/Akt signaling pathway.]. Zhong Xi Yi Jie He Xue Bao 2011;9(5): 533-38.

58. Chao X, Zao J, Xiao-Yi G, Li-Jun M, Tao S. Blocking of PI3K/AKT induces apoptosis by its effect on NF-kappaB activity in gastric carcinoma cell line SGC7901. Biomed Pharmacother 2010;64(9): 600-4.

59. Cheong JW, Min YH, Eom JI, Kim SJ, Jeung HK, Kim JS. Inhibition of CK2{alpha}

and PI3K/Akt synergistically induces apoptosis of CD34+CD38- leukaemia cells while sparing haematopoietic stem cells. Anticancer Res 2010;30(11): 4625-34.

60. Woods Ignatoski KM, Livant DL, Markwart S, Grewal NK, Ethier SP. The role of phosphatidylinositol 3'-kinase and its downstream signals in erbB-2-mediated transformation. Mol Cancer Res 2003;1(7): 551-60.

61. Yano S, Tokumitsu H, Soderling TR. Calcium promotes cell survival through CaM-K kinase activation of the protein-kinase-B pathway. Nature 1998;396(6711): 584-7.

62. Danial NN, Gramm CF, Scorrano L, et al. BAD and glucokinase reside in a mitochondrial complex that integrates glycolysis and apoptosis. Nature 2003;424(6951):

952-6.

63. Wang HG, Pathan N, Ethell IM, et al. Ca2+-induced apoptosis through calcineurin dephosphorylation of BAD. Science 1999;284(5412): 339-43.

64. Springer JE, Azbill RD, Nottingham SA, Kennedy SE. Calcineurin-mediated BAD dephosphorylation activates the caspase-3 apoptotic cascade in traumatic spinal cord injury.

J Neurosci 2000;20(19): 7246-51.

65. Rao RV, Hermel E, Castro-Obregon S, et al. Coupling endoplasmic reticulum stress to the cell death program. Mechanism of caspase activation. J Biol Chem 2001;276(36):

33869-74.

66. McCullough KD, Martindale JL, Klotz LO, Aw TY, Holbrook NJ. Gadd153 sensitizes cells to endoplasmic reticulum stress by down-regulating Bcl2 and perturbing the cellular redox state. Mol Cell Biol 2001;21(4): 1249-59.

67. Bergner A, Huber RM. Regulation of the endoplasmic reticulum Ca(2+)-store in cancer.

Anticancer Agents Med Chem 2008;8(7): 705-9.

68. Liu H, Qian J, Wang F, et al. Expression of two endoplasmic reticulum stress markers, GRP78 and GADD153, in rat retinal detachment model and its implication. Eye (Lond) 2010;24(1): 137-44.

69. Fumarola C, Guidotti GG. Stress-induced apoptosis: toward a symmetry with receptor-mediated cell death. Apoptosis 2004;9(1): 77-82.